Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Indrayani Biotech
Join Channel
Consolidated Standalone

Indrayani Biotech

₹56.9 2.7 | 5%

Market Cap ₹259 Cr.

Stock P/E 41.7

P/B 4

Current Price ₹56.9

Book Value ₹ 14.2

Face Value 10

52W High ₹99.7

Dividend Yield 0%

52W Low ₹ 46.8

Edit Ratio

Indrayani Biotech Research see more...

Overview Inc. Year: 1992Industry: Floriculture

Indrayani Biotech Ltd is a cutting-edge biotechnology company that specializes in the development and commercialization of innovative solutions for various sectors, including healthcare, agriculture, and environmental sustainability. With a strong focus on research and development, the company leverages advanced biotechnological techniques to create novel products and services. In the healthcare domain, Indrayani Biotech Ltd pioneers the development of groundbreaking pharmaceuticals, diagnostics, and therapeutic solutions, aiming to improve patient outcomes and address unmet medical needs. Their expertise extends to agricultural biotechnology, where they devise sustainable methods to enhance crop productivity, develop disease-resistant varieties, and promote efficient resource management. Indrayani Biotech Ltd also places significant emphasis on environmental sustainability by developing eco-friendly technologies, such as biofuels and waste management solutions. The company actively collaborates with academic institutions, research organizations, and industry partners to foster innovation and accelerate the translation of scientific advancements into practical applications. With a commitment to excellence and a passion for transformative biotechnology, Indrayani Biotech Ltd strives to make a positive impact on society and contribute to a healthier and more sustainable future.

Read More..

Indrayani Biotech Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Indrayani Biotech Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 15 15 17 26 42 46 49 42 40 39
Other Income 0 0 0 0 2 0 2 0 0 0
Total Income 15 15 17 26 44 46 51 42 41 39
Total Expenditure 13 13 15 23 37 40 46 40 33 36
Operating Profit 2 2 2 3 7 6 5 3 7 4
Interest 1 1 0 1 1 1 2 2 1 1
Depreciation 0 0 0 1 1 1 1 1 1 1
Exceptional Income / Expenses 0 0 0 0 -0 -0 0 0 0 0
Profit Before Tax 1 1 2 2 5 3 2 -0 6 1
Provision for Tax 0 0 0 -0 0 -0 0 0 0 0
Profit After Tax 1 1 2 2 5 3 1 -0 6 1
Adjustments 0 0 -0 -0 -2 -1 -0 0 -2 -0
Profit After Adjustments 1 1 2 2 4 2 1 -0 3 1
Adjusted Earnings Per Share 0.3 0.3 0.4 0.5 1 0.7 0.3 -0.1 0.9 0.2

Indrayani Biotech Profit & Loss

#(Fig in Cr.) Mar 2011 Mar 2012 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 39 58 50 21 62 163 170
Other Income 0 0 0 0 0 4 2
Total Income 39 58 50 21 62 167 173
Total Expenditure 39 57 47 26 55 146 155
Operating Profit 1 1 3 -5 7 22 19
Interest 0 0 1 2 2 6 6
Depreciation 0 0 1 0 1 3 4
Exceptional Income / Expenses 0 0 0 -4 0 -1 0
Profit Before Tax 0 0 1 -11 4 12 9
Provision for Tax 0 0 0 0 0 0 0
Profit After Tax -0 -0 1 -11 4 12 8
Adjustments 0 0 0 0 0 -3 -2
Profit After Adjustments -0 -0 1 -11 4 9 5
Adjusted Earnings Per Share -0.1 -0.2 2.2 -3.2 1.3 2.6 1.3

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 163% 48% 33% 0%
Operating Profit CAGR 214% 94% 86% 0%
PAT CAGR 200% 129% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -19% 113% 61% NA%
ROE Average 35% -19% -3% -3%
ROCE Average 22% 5% 6% 8%

Indrayani Biotech Balance Sheet

#(Fig in Cr.) Mar 2011 Mar 2012 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 4 3 31 20 24 55
Minority's Interest 0 0 0 0 0 -7
Borrowings 2 0 7 8 7 29
Other Non-Current Liabilities 0 0 0 0 1 6
Total Current Liabilities 4 9 14 12 19 72
Total Liabilities 10 12 51 40 51 156
Fixed Assets 6 6 17 15 17 57
Other Non-Current Assets 0 0 15 16 16 21
Total Current Assets 4 7 19 9 19 78
Total Assets 10 12 51 40 51 156

Indrayani Biotech Cash Flow

#(Fig in Cr.) Mar 2011 Mar 2012 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 1 1 2
Cash Flow from Operating Activities 1 2 6 0 4 16
Cash Flow from Investing Activities -3 -0 -4 -1 -1 -47
Cash Flow from Financing Activities 2 -1 -1 -0 -3 33
Net Cash Inflow / Outflow 0 1 1 -1 1 2
Closing Cash & Cash Equivalent 0 1 1 1 2 3

Indrayani Biotech Ratios

# Mar 2011 Mar 2012 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -0.13 -0.18 2.22 -3.25 1.3 2.55
CEPS(Rs) 0.64 0.6 5 -3.14 1.49 4.46
DPS(Rs) 0 0 0 0 0 0
Book NAV/Share(Rs) 9.67 9.51 0.7 5.76 7.06 12.94
Core EBITDA Margin(%) 1.89 0.88 5.56 -23.44 11.01 10.62
EBIT Margin(%) 1.18 0.73 3.93 -43.83 10.28 11.02
Pre Tax Margin(%) 0.26 0.04 1.62 -53.18 7.21 7.55
PAT Margin (%) -0.12 -0.11 1.62 -53.18 7.21 7.32
Cash Profit Margin (%) 0.59 0.38 3.65 -51.01 8.28 9.38
ROA(%) -0.87 -0.59 2.53 -24.5 9.71 11.51
ROE(%) -2.84 -1.85 43.42 -112.29 20.23 34.86
ROCE(%) 16.17 7.69 7.85 -23.16 16.38 22.45
Receivable days 13.19 22.13 41.11 102.23 55.92 49.36
Inventory Days 0 0 37.1 53.33 7.77 15.4
Payable days 0 0 60.37 111 40.71 50.99
PER(x) 0 0 3.77 0 23.51 22.14
Price/Book(x) 0 0 12 1.1 4.32 4.37
Dividend Yield(%) 0 0 0 0 0 0
EV/Net Sales(x) 0.14 0.07 0.31 1.74 1.96 1.61
EV/Core EBITDA(x) 7.55 6.08 5.17 -7.82 17.25 12.04
Net Sales Growth(%) 0 47.68 -13.94 -57.74 191.97 164.61
EBIT Growth(%) 277.55 -8.17 362.02 -571.81 168.48 183.55
PAT Growth(%) 84.14 -39.87 1346.41 -1489.05 139.59 168.74
EPS Growth(%) 74.47 -39.97 1346.41 -246.65 139.92 96.79
Debt/Equity(x) 0.62 0.53 54.18 0.79 0.74 1.17
Current Ratio(x) 1.01 0.77 1.4 0.78 0.97 1.08
Quick Ratio(x) 1.01 0.78 1.03 0.68 0.89 0.91
Interest Cover(x) 1.29 1.06 1.7 -4.69 3.35 3.18
Total Debt/Mcap(x) 0 0 4.52 0.71 0.17 0.32

Indrayani Biotech Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 50.17 48.81 44.91 44.89 44.89 44.89 44.89 44.84 33.63 33.57
FII 0 0 0 0 0 0 0 0 0 0
DII 22.04 22.04 22.04 19.17 17.16 17.03 15.27 13.11 7.58 6.75
Public 27.79 29.15 33.05 35.94 37.95 38.08 39.83 42.05 58.79 59.68
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

Cons

  • Promoter holding is low: 33.57%.
  • Company has a low return on equity of -19% over the last 3 years.
  • Debtor days have increased from 40.71 to 50.99days.
  • Stock is trading at 4 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Indrayani Biotech News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!